Meaningful changes to DIR fees are on the horizon—will pharmacies see an increase in reimbursements?
Why Asti’s delivery service sets it apart—and how it helps patients.
Time for a little civic pride! Did your city make the list?
A new study puts a huge number on how much nonoptimized medication use costs.
Diabetes drug empagliflozin reduces fat levels in type 2 patients, which may reduce risk of severe liver disease.
Easy-to-swallow bits of news and studies for the busy pharmacist.
Missing teeth could be a signal that diabetes may be developing.
There is plenty for community pharmacists to worry about, but there is a light at the end of the tunnel.
Reimbursement issues, sadly, aren’t anything new for pharmacies.
What do pharmacies have to do with the recent Surgeon General Advisory? A lot, actually.